Kun Hua1, Rui Zhao2, Zhan Peng1, Yunxiao Yang1, Osmanaj Florian1, Bin Mao1, Xiubin Yang1,2. 1. Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Vessel Disease, Beijing, China. 2. Department of Cardiovascular Surgery, Fuwai Hospital, National Centre for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Abstract
BACKGROUND: Tricuspid regurgitation (TR) usually remains asymptomatic for a long time, such that it is most often diagnosed at an advanced stage of right heart failure. The purpose of this study was to identify clinical characteristics and overall outcomes in patients with severe TR who received tricuspid valve replacement (TVR) at different clinical stages. METHODS: Between 1993 and 2018, 256 severe TR patients who received TVR alone or in combination with other procedures were assessed at Beijing Anzhen Hospital. Ninety-three patients underwent New York Heart Association (NYHA) class I/II operations (early surgery group), and the others underwent NYHA class III/IV operations. The primary outcome was in-hospital and long-term mortality. Clinical outcomes were evaluated by the Kaplan-Meier method and Cox regression models. Follow-up was conducted annually. Propensity score matching and overlap propensity score weighting were performed as sensitivity analyses. RESULTS: Postoperative complications, including low cardiac output (11.8% vs. 26.4%, P<0.001), renal failure (2.2% vs. 16.6%, P<0.001), and bleeding (3.2% vs. 11.7%, P=0.037), were significantly lower in the NYHA class I/II group than in the NYHA III/IV group. Patients in the NYHA class III/IV group had a significantly higher incidence of in-hospital mortality (18.4% vs. 5.4%, P<0.001) and long-term mortality (33.7% vs. 11.8%, P=0.006) after follow-up (median follow-up duration =63 months). The results indicated a consistently higher occurrence rate in the propensity score-matched cohort and overlap propensity score weighted analysis. CONCLUSIONS: Consistent with the recent clinical trend to provide earlier and more aggressive TR intervention, our results indicate that surgery for severe TR patients should be considered before advanced heart failure develops, when patients are asymptomatic or mildly symptomatic (NYHA class I/II). 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.
BACKGROUND: Tricuspid regurgitation (TR) usually remains asymptomatic for a long time, such that it is most often diagnosed at an advanced stage of right heart failure. The purpose of this study was to identify clinical characteristics and overall outcomes in patients with severe TR who received tricuspid valve replacement (TVR) at different clinical stages. METHODS: Between 1993 and 2018, 256 severe TR patients who received TVR alone or in combination with other procedures were assessed at Beijing Anzhen Hospital. Ninety-three patients underwent New York Heart Association (NYHA) class I/II operations (early surgery group), and the others underwent NYHA class III/IV operations. The primary outcome was in-hospital and long-term mortality. Clinical outcomes were evaluated by the Kaplan-Meier method and Cox regression models. Follow-up was conducted annually. Propensity score matching and overlap propensity score weighting were performed as sensitivity analyses. RESULTS: Postoperative complications, including low cardiac output (11.8% vs. 26.4%, P<0.001), renal failure (2.2% vs. 16.6%, P<0.001), and bleeding (3.2% vs. 11.7%, P=0.037), were significantly lower in the NYHA class I/II group than in the NYHA III/IV group. Patients in the NYHA class III/IV group had a significantly higher incidence of in-hospital mortality (18.4% vs. 5.4%, P<0.001) and long-term mortality (33.7% vs. 11.8%, P=0.006) after follow-up (median follow-up duration =63 months). The results indicated a consistently higher occurrence rate in the propensity score-matched cohort and overlap propensity score weighted analysis. CONCLUSIONS: Consistent with the recent clinical trend to provide earlier and more aggressive TR intervention, our results indicate that surgery for severe TR patients should be considered before advanced heart failure develops, when patients are asymptomatic or mildly symptomatic (NYHA class I/II). 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.
Entities:
Keywords:
New York Heart Association classification (NYHA classification); Tricuspid regurgitation; tricuspid surgery
Authors: Juraj Madaric; Patrick Watripont; Jozef Bartunek; Filip Casselman; Marc Vanderheyden; Frank Van Praet; William Wijns; Ann Feys; Hugo Vanermen; Bernard De Bruyne Journal: Am Heart J Date: 2007-07 Impact factor: 4.749
Authors: Anand Desai; James D Thomas; Robert O Bonow; Jane Kruse; Adin-Cristian Andrei; James L Cox; Patrick M McCarthy Journal: J Thorac Cardiovasc Surg Date: 2020-11-30 Impact factor: 5.209
Authors: Nishant Saran; Joseph A Dearani; Sameh M Said; Kevin L Greason; Alberto Pochettino; John M Stulak; Simon Maltais; Sertac Cicek; Juan Crestanello; Richard C Daly; Katherine S King; Hartzell V Schaff Journal: Eur J Cardiothorac Surg Date: 2019-11-01 Impact factor: 4.191
Authors: A Marc Gillinov; Tomislav Mihaljevic; Eugene H Blackstone; Kristopher George; Lars G Svensson; Edward R Nowicki; Joseph F Sabik; Penny L Houghtaling; Brian Griffin Journal: Ann Thorac Surg Date: 2010-08 Impact factor: 4.330
Authors: Andrea L Axtell; Vijeta Bhambhani; Philicia Moonsamy; Emma W Healy; Michael H Picard; Thoralf M Sundt; Jason H Wasfy Journal: J Am Coll Cardiol Date: 2019-05-06 Impact factor: 24.094